Lobectomy After Induction Therapy for NSCLC in the Presence of Persistent N2 Disease

Abstract

Patients who undergo induction therapy for N2 NSCLC should have histologically documented N2 disease and should be restaged following induction therapy to determine the post-induction status of the mediastinal lymph nodes. Patients who have demonstrable disease need...